At IQVIA, we are committed to continuing the global effort to proactively fight COVID-19 and keep all of healthcare moving forward. We actively support pharmaceutical companies with new commercial strategies purpose-built for today's marketplace.
We invite you to register now and join this live webinar. We will explore the ongoing impact of COVID-19 on European pharmaceutical markets, including unique insights from HCPs on the prescription of newly launched products as well as a renewed focus on the continued impact of COVID-19 on cancer care, with new learnings from IQVIA's Oncology Dynamics Team.
This webinar will be hosted by IQVIA thought leaders, Sarah Rickwood, VP, European Thought Leadership & Marketing, Claude Henrickx, Sr. Director, Global Oncology Offering Development, Caroline Anger, Associate Director, Global Oncology Offering Development and Dr Nicole Friedersdorf, Global Oncology Associate Product & Strategy Director.
Gain new insights into:
- COVID-19's impact on HCP's intent-to-prescribe newly launched pharmaceutical products
- Oncology patient care in times of COVID-19 – a comparative analysis pre-pandemic vs. present
- How HCP engagement patterns changed during the pandemic
Following the presentation, our team of experts will host a Q&A session. We highly encourage your participation.
We look forward to sharing our insights with you.